HQ Spcs' Generic Esmolol Hydrochloride Receives Approval in the U.S.
Eugia Pharma's Generic Esmolol Hydrochloride Receives Approval in the U.S.
Gland Pharma`s Generic Esmolol Hydrochloride Receives Approval in US
HERTFORDSHIRE, England and PITTSBURGH, Sept. 13, 2018 /PRNewswire/ -- Global pharmaceutical company Mylan N.V. (NASDAQ : MYL ) today announced the U.S. launch of Esmolol Hydrochloride in Sodium Chloride Injection, 2,500 mg/250 mL (10 mg/mL) Single-Dose Plastic Bag and 2,000 mg/100 mL (20 mg/mL) Single-Dose Plastic Bag, the first generic version of the reference listed drug, Baxter's Brevibloc®.
Sagent Pharms Generic Esmolol Hydrochloride Receives Approval In US
Mylan Labs Generic Esmolol Hydrochloride Receives Approval In US
Enforcement Report - Week of February 28, 2018
Gland Pharma Ltd Generic Esmolol Hydrochloride Approved In US
US FDA Enforcement Report- 18/May/2016